Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. [electronic resource]
Producer: 20090921Description: 184-92 p. digitalISSN:- 1095-953X
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Antiparkinson Agents -- adverse effects
- Benzopyrans -- pharmacology
- Callithrix
- Corpus Striatum -- drug effects
- Disease Models, Animal
- Dopamine Antagonists -- pharmacology
- Dopamine and cAMP-Regulated Phosphoprotein 32 -- metabolism
- Dyskinesia, Drug-Induced -- etiology
- Enkephalins -- metabolism
- Female
- Levodopa -- adverse effects
- Male
- Oxidopamine
- Parkinsonian Disorders -- chemically induced
- Protein Precursors -- metabolism
- Pyrroles -- pharmacology
- RNA, Messenger -- metabolism
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine D1 -- metabolism
- Receptors, Dopamine D2 -- metabolism
- Receptors, Dopamine D3 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.